Experimentica’s poster evidently illustrating the effectivity of Aflibercept, administered systemically, protection against the development of neovascular lesions - will be presented in today’s afternoon poster session.
And for the first time - a demonstration of convolutional neural network trained to recognize and quantify choroidal neovascularization lesion using Aiforia® Cloud.
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!